Clinical Trials Logo

Cancer of Colon clinical trials

View clinical trials related to Cancer of Colon.

Filter by:

NCT ID: NCT05030090 Completed - Malnutrition Clinical Trials

Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer

Start date: June 25, 2021
Phase: N/A
Study type: Interventional

At present, the families of cancer patients are lack knowledge and experience of nutritional care after discharge. As a result, cancer patients often suffer from low nutritional status after being discharged from the hospital.

NCT ID: NCT04971304 Completed - Clinical trials for Lymphoma, Non-Hodgkin

Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars

Start date: March 1, 2015
Phase:
Study type: Observational

This comparative effectiveness and descriptive retrospective cohort study will evaluate safety and effectiveness outcomes among commercially insured adults who received a granulocyte colony stimulating factor (G-CSF) biosimilar or originator product during the first cycle of clinical guideline-indicated intermediate or high febrile neutropenia risk chemotherapy.

NCT ID: NCT04880772 Completed - Liver Metastases Clinical Trials

Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery

SPECS
Start date: July 15, 2021
Phase: N/A
Study type: Interventional

To determine whether exercise and nutrition prehabilitation improves patient outcomes after cancer surgery

NCT ID: NCT04812743 Terminated - Cancer of Colon Clinical Trials

Colorectal Health Research Champions

Start date: January 10, 2020
Phase: N/A
Study type: Interventional

The purpose of the Colorectal Health Research Champions program is to provide accurate and reliable colorectal health cancer information that they can share within their communities to encourage cancer prevention, screening, and early detection, as well as the importance of participating in research.

NCT ID: NCT04773626 Not yet recruiting - Cancer of Colon Clinical Trials

Tumor Deposits in Cancer Colon

Start date: June 2021
Phase:
Study type: Observational

1. Assessment of correlation between tumor deposits and clinicopathological characteristics of colorectal cancer. 2. Detection of association between tumor deposits and stage of colorectal cancer. 3. Evaluate the relationship between tumor deposits and prognosis of colorectal cancer patient.

NCT ID: NCT04716010 Completed - Cancer of Colon Clinical Trials

Developing and Evaluating Product Messaging

Start date: October 18, 2021
Phase: N/A
Study type: Interventional

Purpose: To assess the impact of taxes, warnings, and a combination of taxes and warnings on US adults' decisions to purchase products that contain red meat in an online grocery store. Procedures (methods): Participants will be recruited from Prime Panels (an online panel research company). Following online consent, participants will be assigned to one of four trial arms: 1) Control (no warning and no tax), 2) Warnings (all products that contain red meat have a health warning and environmental warning), 3) Tax (30% tax on products that contain red meat), and 4) Combined warning and tax (all products that contain red meat will have the two warnings and a 30% tax). Then, participant will enter an online grocery store reflecting their assigned arm. The participant will be instructed to complete a shopping task in the online grocery store. After completing the shopping task, participants will be redirected to an online survey and answer a series of questions about the shopping task, labels (excluding tax and control groups), and taxes (excluding warning and control groups). Questions will also include standard demographic and health related variables.

NCT ID: NCT04274790 Withdrawn - Cancer of Colon Clinical Trials

Impact of 5-Fluorouracil (5-FU) on Cancer Cells From Liver Metastases of Colon Cancer

FLUORIB
Start date: June 1, 2021
Phase:
Study type: Observational

Analyze the dynamics of incorporation of 5-fluorouracil into cancer cell ribosomes from liver metastases of patient with metastatic colon cancer.

NCT ID: NCT04259398 Active, not recruiting - Anesthesia Clinical Trials

Anesthesia and Cancer Study: Colon Cancer

Start date: February 18, 2020
Phase: N/A
Study type: Interventional

This study investigates the influence of type of anesthesia on survival and recurrence rate in patients receiving colon cancer surgery. The participants will be allocated to either the TIVA group and the inhalation group.

NCT ID: NCT04198025 Not yet recruiting - Cancer of Colon Clinical Trials

Psoas Density in Colorectal Cancer

Start date: January 1, 2020
Phase:
Study type: Observational

Colorectal cancer (CRC) is the 3rd most common cancer worldwide. In the UK, CRC is the 4th most common cancer accounting for 12% of cancers diagnosed each year with approximately 41,300 new cases diagnosed in 2014. Surgery remains the only treatment option that can reliably achieve cure from colorectal cancer and thus nearly 20,000 major bowel resections are performed for this yearly in the UK. Surgery for these cancers however carries risk of major complications and potentially death. Selecting appropriate patients for surgery remains a challenge to cancer teams. Risk factors exist for complications after surgery for CRC, many of which can be assessed and discussed with the patient prior to surgery, so that any decision to operate is with fully informed consent from the patient. Increasing attention is being paid to a patient's frailty or fitness as one of these risk factors. Our centre has previously shown that measuring the cross-sectional area of the psoas muscle (a large muscle near the spine) from preoperative imaging could predict major complications in colorectal cancer patients (Jones 2015), however specialist software and patient height is required to make this calculation. More recently we have demonstrated that the measurement of the psoas muscle density on preoperative imaging (i.e. routine CT scans that all patients have before surgery to plan treatment), may potentially be useful to predict which patients are at most risk of a major complication (Herrod 2019). If this finding holds true when tested on a larger scale, it could be used to help surgical teams make the decision on whether to offer surgical resection, what kind of operations to perform, how to best support individuals undergoing operation and to ensure that the patient has the most information available to decide what risk they are at by having major surgery.

NCT ID: NCT04160650 Completed - Patient Empowerment Clinical Trials

Educational Nursing Intervention Among Patients With Colorectal Cancer During Chemotherapy

Start date: October 21, 2019
Phase: N/A
Study type: Interventional

The prevalence of malnutrition is common among patients with colorectal cancer. Chemotherapy induced side effects may impact negatively on nutrition intake thus increase the risk of malnutrition and serious complications for patients. Purpose is to test the effect of empowering education on activation and knowledge level among patients with colorectal cancer during the chemotherapy. Secondary outcomes are quality of life and malnutrition. A two-arm, single center, patient blinded superiority trial with stratified randomization (1:1) and with repeated measures is used to measure the effectiveness of face-to-face education on nutrition intake related chemotherapy induced side-effects' self-care compared to standard care. Eligibility criteria are adult patients diagnosed with colorectal cancer and receiving intra venous chemotherapy treatment. Patients are recruited in one university hospital outpatient clinic in Finland. Experienced oncology nurse delivers the intervention two weeks after the first chemotherapy. Primary outcomes are activation in self-care and knowledge level. Secondary outcomes are quality of life and risk of malnutrition measured at baseline (M0) and after eight (M1) and 16 weeks (M2) after the intervention. The study will provide knowledge of nurse-led educational intervention on self-care among patients with colorectal cancer. The findings will contribute to patient education and self-care, thus better quality of life.